HIV 1 News and Research

RSS

AIDS Healthcare Foundation bans Merck's sales representatives for unwarranted pricing of Isentress

AIDS Healthcare Foundation, the largest global AIDS organization which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe, including 18 healthcare centers in California, Florida, and Washington, DC, has banned pharmaceutical sales representatives from Merck and Co. Pharmaceuticals, from calling on AHF’s medical providers and staff in its US healthcare centers.

27 Jan 2010

Number of Americans in excellent or good health has declined

The New York Times reports on health in the U.S. "The percentage of people who reported having excellent or very good health declined to 66.6 percent in the 2009 period, from 69.1 percent in 1998.

27 Jan 2010

Abbott submits Premarket Approval application for the ARCHITECT HIV Ag/Ab Combo assay to FDA

An assay to aid in the early detection of HIV infection may soon be available in the United States. Abbott announced today it has submitted a Premarket Approval application for the ARCHITECT HIV Ag/Ab Combo assay to the U.S. Food and Drug Administration (FDA) for expedited review. Upon approval, the assay is expected to be the first test available in the United States to simultaneously detect the combined presence of HIV antigens (proteins produced by the HIV virus) and antibodies (proteins produced by the body to fight HIV antigens), which would allow for the early detection and ongoing monitoring of the virus.

26 Jan 2010

Institute of Medicine urges healthcare providers to take steps to battle hepatitis B and C

The Institute of Medicine, a branch of the US National Academy of Sciences, is urging healthcare providers to take steps to battle liver-damaging hepatitis B and C, which are often overlooked viruses.

25 Jan 2010

Bill Gates' annual letter highlights innovations aimed at combating disease, hunger and poverty

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, today released his second annual letter -- a personal appraisal of the foundation's efforts to date and how innovation impacts priorities of the foundation.

25 Jan 2010

Partners In Health reports latest developments in Haiti

In spite of the recent aftershocks, which have caused temporary evacuations at medical facilities in some locations, the PIH team reports having gotten 24 operating rooms up and running, providing urgent care 24 hours per day, including 12 at the central University Hospital in Port-au-Prince (HUEH) and seven at four of our medical facilities outside the capital.

23 Jan 2010

Recent releases in global health

"Picture the situation in Haiti: families living on top of sewage-contaminated rubbish dumps, with no reliable sources of food and water and virtually no access to health care. This scenario depicts the situation in Haiti before the earthquake that catapulted this impoverished and conflict-ridden country into the international headlines,"

23 Jan 2010

AHF/Magic Johnson ‘Testing America’ tour to conduct testing event at Albuquerque, New Mexico

AHF’s Magic Johnson ‘Testing America’ Tour, a six month, 48 state national cross country HIV testing tour, will tumble into Albuquerque, New Mexico for a testing event at El Mezquite Market from 10am to 2pm Friday January 22nd. Free testing will take place on AHF’s new, state-of-the-art ‘Testing America’ mobile HIV testing unit. AHF is working in conjunction with New Mexico AIDS Services, a respected local non-profit HIV/AIDS organization.

22 Jan 2010

OHAfrica reaches significant milestone in HIV/AIDS treatment program in Africa

For more than five years, OHAfrica - through Tšepong Clinic - has helped support HIV/AIDS treatment and testing in Lesotho, a small country in southern Africa with the third highest HIV infection rate in the world.

22 Jan 2010

Controversy around Merck's pricing for its AIDS drug Isentress

The controversy around Merck and Co. Pharmaceuticals’ pricing for its key AIDS drug Isentress — at nearly $13,000 per patient yearly, the most expensive first line AIDS therapy on the US market today — continued this week following Merck’s reaction to recent public criticism of its AIDS drug pricing. Merck ramped up its damage control PR efforts, issuing a press release that sought to rewrite the history of Isentress and deflect attention by claiming AIDS Healthcare Foundation has been unfairly attacking them.

22 Jan 2010

HIV infection causes premature aging of the brain

HIV infection or the treatments used to control it are prematurely aging the brain, researchers at Washington University School of Medicine in St. Louis and the University of California-San Diego have found.

22 Jan 2010

NABJ to hold annual conference on Health Disparities

The National Association of Black Journalists (NABJ) will hold its annual conference on Health Disparities, March 4-6, 2010 at the Barbara Jordan Conference Center at Kaiser Family Foundation in Washington, D.C. The conference will provide journalists the tools to effectively report on the impact of health, health policy and health care reform on communities of color.

21 Jan 2010

New research suggests prolong breastfeeding is critical for reducing risk of gastroenteritis in infants

For African infants with HIV-positive mothers, reducing exposure to breast milk can lower the rate of HIV transmission. But new research suggests that longer periods of breastfeeding—at least 6 months—are critical for reducing the risk of potentially fatal gastroenteritis.

21 Jan 2010

Study: PrEP treatment offers protection against HIV transmission in humanized mice

Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.

21 Jan 2010

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

21 Jan 2010

GSK to offer scientists access to compounds, lab space to fight malaria

Drugmaker GlaxoSmithKline (GSK)'s Chief Executive Officer Andrew Witty on Tuesday unveiled the company's plans to allow "free access to its library of 13,500 potential malaria treatments and devote the profits from its experimental [RTS,S] vaccine to battling tropical illnesses that beset poor countries," Bloomberg reports (Randall, 1/20).

21 Jan 2010

Circumcising newborn males cost effective strategy for HIV prevention, Rwandan study finds

Performing circumcisions on newborn boys to lower their risk for HIV infection later in life is more cost-effective than adolescent or adult circumcision, according to researchers at Rwanda's health ministry, Reuters reports.

21 Jan 2010

QuantRx Biomedical's developments in genetics-based technology

QuantRx® Biomedical Corporation, a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today provided an update from Chairman and Chief Executive Officer Walter Witoshkin on its involvement in genetics-based personalized medicine and disease prevention.

20 Jan 2010

UCI finding could complicate quest to eradicate deadly disease in humans

Chimpanzees were known to carry the parasite Plasmodium reichenowi, but most scientists assumed the two parasites had existed separately in humans and chimpanzees for the last 5 million years.

20 Jan 2010

National Institutes of Mental Health awards $8M for HIV research

A multidisciplinary research team at the Johns Hopkins University School of Medicine has been awarded $8 million in funding by the National Institutes of Mental Health to develop methods to rid the body of HIV.

20 Jan 2010

HIV 1 News and Research

AIDS Healthcare Foundation bans Merck's sales representatives for unwarranted pricing of Isentress

Number of Americans in excellent or good health has declined

Abbott submits Premarket Approval application for the ARCHITECT HIV Ag/Ab Combo assay to FDA

Institute of Medicine urges healthcare providers to take steps to battle hepatitis B and C

Bill Gates' annual letter highlights innovations aimed at combating disease, hunger and poverty

Partners In Health reports latest developments in Haiti

Recent releases in global health

AHF/Magic Johnson ‘Testing America’ tour to conduct testing event at Albuquerque, New Mexico

OHAfrica reaches significant milestone in HIV/AIDS treatment program in Africa

Controversy around Merck's pricing for its AIDS drug Isentress

HIV infection causes premature aging of the brain

NABJ to hold annual conference on Health Disparities

New research suggests prolong breastfeeding is critical for reducing risk of gastroenteritis in infants

Study: PrEP treatment offers protection against HIV transmission in humanized mice

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

GSK to offer scientists access to compounds, lab space to fight malaria

Circumcising newborn males cost effective strategy for HIV prevention, Rwandan study finds

QuantRx Biomedical's developments in genetics-based technology

UCI finding could complicate quest to eradicate deadly disease in humans

National Institutes of Mental Health awards $8M for HIV research

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News